Akero Therapeutics, Inc. (AKRO)

Last Closing Price: 49.65 (2025-05-30)

Receiveable Turnover (Quarterly)

Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable

Akero Therapeutics, Inc. (AKRO) Receiveable Turnover data is not available.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
--
$-70.72M
--
--
$80.88M
$-80.88M
$10.16M
$-70.72M
$-70.72M
$-70.72M
$-70.72M
$-70.72M
$-70.72M
$-80.88M
$-83.17M
78.66M
78.66M
$-0.90
$-0.90
Balance Sheet Financials
$713.15M
--
$442.69M
$1.16B
$42.44M
$29.11M
$29.56M
$72.00M
$1.08B
$1.08B
$1.08B
79.67M
Cash Flow Statement Financials
$-67.66M
$-482.18M
$395.53M
$340.24M
$185.92M
$-154.32M
$8.78M
--
--
Fundamental Metrics & Ratios
16.80
--
--
0.03
0.03
--
--
--
--
--
--
$-67.66M
--
--
--
--
--
Receiveable Turnover
--
--
-6.53%
-6.53%
-6.12%
-6.35%
$13.60
$-0.86
$-0.86